1. Home
  2. AVY vs ALGN Comparison

AVY vs ALGN Comparison

Compare AVY & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avery Dennison Corporation

AVY

Avery Dennison Corporation

HOLD

Current Price

$187.17

Market Cap

14.6B

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$167.09

Market Cap

12.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVY
ALGN
Founded
1935
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6B
12.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AVY
ALGN
Price
$187.17
$167.09
Analyst Decision
Buy
Buy
Analyst Count
11
11
Target Price
$204.09
$174.00
AVG Volume (30 Days)
594.2K
808.8K
Earning Date
02-04-2026
02-04-2026
Dividend Yield
2.00%
N/A
EPS Growth
5.74
N/A
EPS
8.81
5.16
Revenue
$8,770,000,000.00
$3,982,622,000.00
Revenue This Year
$2.37
$2.58
Revenue Next Year
$4.40
$3.66
P/E Ratio
$21.38
$32.48
Revenue Growth
1.03
0.56
52 Week Low
$156.23
$122.00
52 Week High
$196.41
$234.19

Technical Indicators

Market Signals
Indicator
AVY
ALGN
Relative Strength Index (RSI) 55.58 53.93
Support Level $181.64 $164.44
Resistance Level $188.73 $172.36
Average True Range (ATR) 3.85 4.16
MACD -0.24 -0.82
Stochastic Oscillator 66.59 22.03

Price Performance

Historical Comparison
AVY
ALGN

About AVY Avery Dennison Corporation

Avery Dennison manufactures pressure-sensitive materials, merchandise tags, and labels. The company also runs a specialty converting business that produces radio-frequency identification inlays and labels. Avery Dennison draws a significant amount of revenue from outside the United States, with international operations accounting for the majority of total sales.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: